A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients With Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2018
At a glance
- Drugs Glucagon (Primary) ; Glucagon
- Indications Hypoglycaemia
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 26 Mar 2018 Planned End Date changed from 15 Sep 2018 to 31 Aug 2018.
- 26 Mar 2018 Planned primary completion date changed from 15 Aug 2018 to 31 Jul 2018.
- 09 Feb 2018 Status changed from not yet recruiting to recruiting.